6-Month Chronic Efficacy & Safety Study of Eszopiclone in Adult Subjects With Primary Insomnia
Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
To evaluate the long-term efficacy of eszopiclone administered for up to 6 months in subjects
with primary insomnia on subjective sleep measures, compared to placebo.